Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | The impact of COVID-19 on clinical research

Melvin L. K Chua • 29 Apr 2020
Head and Neck Cancer

Melvin L.K. Chua, MBBS, FRCR, PhD, National Cancer Center Singapore, Singapore, discusses the impact of COVID-19 on clinical research in patients with head and neck cancers. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Melvin L. K Chua

International consortium for COVID-19 paper
10:46
International consortium for COVID-19 paper
Melvin L. K Chua • 29 Apr 2020
COVID-19: risk of cancer patients to infection
11:34
COVID-19: risk of cancer patients to infection
Melvin L. K Chua • 29 Apr 2020

Related Videos

Phase II study of FID-007 plus cetuximab in recurrent or metastatic HNSCC
1:04
Phase II study of FID-007 plus cetuximab in recurrent or metastatic HNSCC
Jacob Thomas • 31 May 2026
TARGET-HPV: neoadjuvant HPV16-targeted immunotherapy in oropharyngeal cancer
2:24
TARGET-HPV: neoadjuvant HPV16-targeted immunotherapy in oropharyngeal cancer
Ari Rosenberg • 31 May 2026
NRG-HN015: Phase II trial of perioperative systemic therapy in recurrent head and neck cancer
3:11
NRG-HN015: Phase II trial of perioperative systemic therapy in recurrent head and neck cancer
Nabil Saba • 1 Jun 2026
INO-3107 and B-cell immunity: implications for HPV-associated cancers
1:29
INO-3107 and B-cell immunity: implications for HPV-associated cancers
Nabil Saba • 1 Jun 2026
The content of VJOncology is intended for healthcare professionals